Corporate Research Group’s Weblog

Corporate Research Group has been serving the managed healthcare marketplace since 1993 as the industry’s leading source for news, strategic intelligence, market research and custom consulting.  CRG’s various information products include the Health Plan Market Trends Letter, Outlook for Managed Care, and various e-mail updates, annual forecasts and conferences. Disclosure: Many leading health plans, managed care services companies, and other healthcare organizations have retained CRG for specialized consulting projects and targeted information services – including companies covered in our newsletters, reports and blog.

Bios of contributors to the CRG blog:

CARL MERCURIO is president of Corporate Research Group, overseeing a broad-based franchise in healthcare information publishing. Thousands of healthcare industry executives rely on Mercurio’s commentary and expertise for strategic planning, market research and new product development. Mercurio has 20 years of experience in consulting, market analysis, and information publishing. Prior to joining CRG, Mercurio was editorial director of Simba Information, which publishes newsletters and research reports on the media industry. He is a graduate of the University of Connecticut.  Email: carl.mercurio@corporateresearchgroup.com

BOAS GONEN, M.D., is a consultant (president of Pharmagon Inc.) on new drug development and evaluation, as well as business development in the pharmaceutical industry. He is board certified in Internal Medicine and Endocrinology/Metabolism, with 11 years experience in academic medicine (last academic position: Associate Professor of Medicine and acting head of the Endocrine division at Thomas Jefferson Medical College in Philadelphia), and 15 years in the Pharmaceutical Industry (including senior R&D positions at Wyeth for 10 years and Teva Pharmaceuticals for 2 years). He has directed all stages of clinical development (mostly in areas of Diabetes, Obesity, Bone disease, Neurology and Cardiovascular/Lipid disorders), and reviewed hundreds of products and companies (for licensing, M&A and investment activities). Most recently, he co-founded two start-ups in the field of diabetes and nutrition.